| 1 |
Sethi S,Hernandez LH,Alexander MP, et al. C4d as a marker for masked immune deposits[J]. Kidney International, 2016, 90(1): 223-224.
|
| 2 |
Sellarés J,de Freitas DG,Mengel M, et al. Understanding the causes of kidney transplant failure：the dominant role antibody mediated rejection and nonadhererence[J]. Am J Transplant, 2012, 12(2): 388-399.
|
| 3 |
González-Molina M,Ruiz-Esteban P,Caballero A, et al. Immune response and histology of humoral rejection in kidney transplantation[J]. Nefrologia, 2016, 36(4): 354-367.
|
| 4 |
Kikic Z,Kozakowski N,Regele H, et al. Clinicopathological relevance of granular C4d deposition in peritubular capillaries of kidney allografts[J]. Transpl Int, 2014, 27(3): 312-321.
|
| 5 |
Hattori Y,Bucy RP,Kubota Y, et al. Antibody-mediated rejection of single class Ⅰ MHC-disparate cardiac allografts[J]. Am J Transplant, 2012, 12(8): 2017-2028.
|
| 6 |
Mengel M,Sis B,Haas M, et al. Banff 2011 meeting report: new concepts in antibody-mediated rejection[J]. Am J Transplant, 2012, 12(3): 563-570.
|
| 7 |
Haas M,Sis B,Racusen LC, et al. Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions[J]. Am J Transplant, 2014, 14(2): 272-283.
|
| 8 |
Loupy A,Lefaucheur C,Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival[J]. N Engl J Med, 2013, 369(13): 1215-1226.
|
| 9 |
Haas M. The significance of C4d staining with minimal histologic abnormalities[J]. Curr Opin Organ Transplant, 2010, 15(1): 21-27
|
| 10 |
Magil AB. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition[J]. Am J Kidney Dis, 2005, 45(6): 1084.
|
| 11 |
Sund S,Reisaeter AV,Scott H, et al. Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies[J]. Clin Nephrol, 2004, 62(2): 121-130.
|
| 12 |
Desvaux D,Le Gouvello S,Pastural M, et al. Acute renal allograft rejections with major interstitial oedema and plasma cell-rich infiltrates: high gamma- interferon expression and poor clinical outcome[J]. Nephrol Dial Transplant, 2004, 19(4): 933-939.
|
| 13 |
Jordan SC,Vo AA. Donor-specific antibodies in allograft recipients: etiology, impact and therapeutic approaches[J]. Curr Opin Organ Transplant, 2014, 19(6): 591-597.
|
| 14 |
Sapir-Pichhadze R,Pcurran S,John R, et al. A systematic review of the role of C4d in the diagnosis of acuteantibody-mediated rejection[J]. Kidney international, 2015, 67(1): 182-194.
|
| 15 |
Regele H,Exner M,Watschinger B, et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection[J]. Nephrol Dial Transplant, 2001, 16(10): 2058-2066.
|
| 16 |
Pedraza N,Girón F,Baez Y, et al. Positive C4d in kidney transplantation biopsy: clinical impact[J]. Transplant Proc, 2014, 46(9): 2966-2971.
|
| 17 |
Feucht HE,Felber E,Gokel MJ, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection[J]. Clin Exp Immunol, 1991, 86(3): 464-470.
|
| 18 |
Feucht HE,Schneeberger H,Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss[J]. Kidney Int, 1993, 43(6): 1333-1338.
|
| 19 |
Crespo M,Pascual M,Tolkoff-Rubin N, et al. Acute humoral rejection in renal allograft recipients: Ⅰ. Incidence, serology and clinical characteristics[J]. Transplantation, 2001, 71(5): 652-658.
|
| 20 |
Haas M,Rahman MH,Racusen LC, et al. C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings[J]. Am J Transplant, 2006, 7(3): 724.
|
| 21 |
Zhang Q,Liang LW,Gjertson DW, et al. Development of posttransplant antidonor HLA antibodies is associated with acute humoral rejection and early graft dysfunction[J]. Transplantation, 2005, 79(5): 591-598.
|
| 22 |
Mohan S,Palanisamy A,Tsapepas D, et al. Donor-specific antibodies adversely affect kidney allograft outcomes[J]. J Am Soc Nephrol, 2012, 23(12): 2061-2071.
|
| 23 |
Wiebe C,Gibson IW,Blydt-Hansen TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant[J]. Am J Transplant, 2012, 12(5): 1157-1167.
|
| 24 |
Loupy A,Lefaucheur C,Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival[J]. N Engl J Med, 2013, 369(13): 1215-1226.
|
| 25 |
Feucht HE. Complement C4d in graft capillaries-the missing link in the recognition of humoral alloreactivity[J]. Am J Transplant, 2003, 3(6): 646-652.
|
| 26 |
Dragun D,Müller DN,Bräsen JH, et al. Angiotensin Ⅱ type 1-receptor activating antibodies in renal-allograft rejection[J]. N Engl J Med, 2005, 352(352): 2027-2028.
|
| 27 |
Fuss A,Hope CM,Deayton S, et al. C4d-negative antibody-mediated rejection with high anti-angiotensin Ⅱ type Ⅰ receptor antibodies in absence of donor-specific antibodies[J]. Nephrology, 2015, 20(7): 467-473.
|
| 28 |
廖涛,启全. 移植肾抗体介导的排斥反应的发病机制研究进展[J]. 器官移植, 2015, 6(4): 276-282.
|
| 29 |
Martin L,Guignier F,Bocrie O, et al. Detection of anti-HLA antibodies with flow cytometry in needle core biopsies of renal transplants recipients with chronic allograft nephropathy[J]. Transplantation, 2005, 79(10): 1459-1461.
|
| 30 |
Verghese P,Dunn T,Najafian B, et al. The impact of C4d and microvascular inflammation before we knew them[J]. Clinical Transplantation, 2013, 27(3): 388-396.
|
| 31 |
Loupy A,Hill GS,Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA) [J]. Am J Transplant, 2011, 11(1): 56-65.
|
| 32 |
de Kort H,Willicombe M,Brookes P, et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies [J]. Am J Transplant, 2013, 3(2): 485-492.
|
| 33 |
Sis B,Jhangri GS,Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining[J]. Am J Transplant, 2009, 9(10): 2312-2323.
|
| 34 |
Mauiyyedi S,Crespo M,Collins AB, et al. Acute humoral rejection in kidney transplantation: Ⅱ. Morphology, immunopathology, and pathologic classification[J]. J Am Soc Nephrol, 2002, 13(3): 779-787.
|
| 35 |
Sampaio WLV,Mazzali M. C4d Deposits in borderline rejection: an early marker for chronic renal dysfunction？[J]. Transplant Proc, 2014, 46(6): 1710-1712.
|
| 36 |
Böhmig GA,Exner M,Habicht A, et al. Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury[J]. J Am Soc Nephrol, 2002, 13(4): 1091-1099.
|
| 37 |
Kedainis RL,Koch MJ,Brennan DC, et al. Focal C4d＋ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival[J]. Am J Transplant, 2009, 9(4): 812-819.
|
| 38 |
Legendre C. Antibody-mediated vascular rejection of kidney allograft: characterization of different kidney allograft rejection phenotypes via histology, C4d deposition and donor-specific antibodies[J]. Clin Exp Immunol, 2014, 178(S1): 59-60.
|